durvalumab,pembrolizumab
astrazeneca,merck
['sclc', 'nsclc', 'pacific', '8508']
#asco22 discussion of #8508 (dr. ), #8509 (dr. ) and #8510 (dr. ohri) focused on radiation + immunotherapy in locally advanced nsclc. immunotherapy essential ever since pacific but still figuring out optimal delivery strategy. is chemo needed? induction helpful? 
Director of Thoracic Oncology & Developmental Therapeutics @LombardiCancer, Associate Professor @Georgetown University #LCSM #HereWeGo #ITYSL He/Him